{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:42:08Z","timestamp":1786545728440,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/ajg.2013.50","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T08:59:27Z","timestamp":1363683567000},"page":"981-989","source":"Crossref","is-referenced-by-count":32,"title":["Birth Cohort Screening for Chronic Hepatitis During Colonoscopy Appointments"],"prefix":"10.14309","volume":"108","author":[{"given":"Dawn M","family":"Sears","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan C","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/653622","article-title":"The prevalence of hepatitis B virus infection in the United States in the era of vaccination.","volume":"202","author":"Wasley","year":"2010","journal-title":"J Infect Dis"},{"key":"R2-23-20210210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"R3-23-20210210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-156-4-201202210-00378","article-title":"The cost-effectiveness of birth-cohort screening for hepatitis C antibody in US primary care settings.","volume":"156","author":"Rein","year":"2012","journal-title":"Ann Intern Med"},{"key":"R4-23-20210210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.dld.2010.05.006","article-title":"Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.","volume":"43","author":"Rein","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R5-23-20210210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.","volume":"156","author":"Ly","year":"2012","journal-title":"Ann Intern Med"},{"key":"R6-23-20210210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2893.2008.01008.x","article-title":"The cost effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis.","volume":"15","author":"Sutton","year":"2008","journal-title":"J Viral Hepat"},{"key":"R7-23-20210210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2458-6-170","article-title":"Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison.","volume":"6","author":"Sutton","year":"2006","journal-title":"BMC Public Health"},{"key":"R8-23-20210210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amepre.2005.03.010","article-title":"Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.","volume":"29","author":"Gunn","year":"2005","journal-title":"Am J Prev Med"},{"key":"R9-23-20210210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.olq.0000154503.41684.5d","article-title":"Integrating hepatitis B prevention into sexually transmitted disease services: US sexually transmitted disease program and clinic trends -1997 and 2001.","volume":"32","author":"Gilbert","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R10-23-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10320","article-title":"The cost-effectiveness of testing for hepatitis C in former injecting drug users.","volume":"10","author":"Castelnuovo","year":"2006","journal-title":"Health Technol Assess"},{"key":"R12-23-20210210","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2169\/internalmedicine.46.0289","article-title":"Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C.","volume":"46","author":"Arase","year":"2007","journal-title":"Intern Med"},{"key":"R13-23-20210210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.20984","article-title":"Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.","volume":"43","author":"Iwasaki","year":"2006","journal-title":"Hepatology"},{"key":"R14-23-20210210","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1572-0241.2006.00556.x","article-title":"Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?","volume":"101","author":"Thabut","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R15-23-20210210","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archinte.1996.00440090123012","article-title":"The cost of a food-borne outbreak of hepatitis A in Denver, Colo.","volume":"156","author":"Dalton","year":"1996","journal-title":"Arch Intern Med"},{"key":"R16-23-20210210","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1016\/j.vaccine.2005.03.060","article-title":"Hepatitis A virus infection in the United States: serologic results from the Third National Health and Nutrition Examination Survey.","volume":"23","author":"Bell","year":"2005","journal-title":"Vaccine"},{"key":"R17-23-20210210","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1016\/j.vaccine.2011.07.030","article-title":"Hepatitis B vaccination coverage among high-risk adults 18-49 years, US 2009.","volume":"29","author":"Lu","year":"2011","journal-title":"Vaccine"},{"key":"R19-23-20210210","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.vaccine.2008.12.054","article-title":"Hepatitis A vaccination coverage among adults aged 18-49 years in the United States.","volume":"27","author":"Lu","year":"2009","journal-title":"Vaccine"},{"key":"R20-23-20210210","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-156-5-201203060-00010","article-title":"Screening for colorectal cancer: a guidance statement from the American College of Physicians.","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"R21-23-20210210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1620\/tjem.215.33","article-title":"Cost-effectiveness of the national screening program for hepatitis C virus in the general population and the high-risk groups.","volume":"215","author":"Nakamura","year":"2008","journal-title":"Tohoku J Exp Med"},{"key":"R22-23-20210210","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/hep.25510","article-title":"Economic model of a birth cohort screening program for hepatitis C virus.","volume":"55","author":"McGarry","year":"2012","journal-title":"Hepatology"},{"key":"R23-23-20210210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.7326\/0003-4819-140-6-200403160-00013","article-title":"Screening for hepatitis C virus infection in adults: recommendation statement.","volume":"140","year":"2004","journal-title":"Ann Intern Med"},{"key":"R24-23-20210210","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.510270505","article-title":"Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C MULTIVIRC Group.","volume":"27","author":"Piton","year":"1998","journal-title":"Hepatology"},{"key":"R25-23-20210210","first-page":"345","article-title":"Family physicians knowledge and screening of chronic hepatitis and liver cancer.","volume":"40","author":"Ferrante","year":"2008","journal-title":"Fam Med"},{"key":"R26-23-20210210","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1572-0241.2004.10370.x","article-title":"Hepatitis C knowledge among primary care residents: is our teaching adequate for the times?","volume":"99","author":"Coppola","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R27-23-20210210","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2004.08.012","article-title":"Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work.","volume":"41","author":"Mostert","year":"2004","journal-title":"J Hepatol"},{"key":"R28-23-20210210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MCG.0b013e31802dc56f","article-title":"Outcomes of a hepatitis C screening program at a large urban VA medical center.","volume":"42","author":"Groom","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R30-23-20210210","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/MCG.0b013e3181e12c09","article-title":"Direct economic burden of chronic hepatitis C virus in a United States managed care population.","volume":"45","author":"Davis","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R31-23-20210210","first-page":"S30","article-title":"The burden of hepatitis C in the United States.","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"R32-23-20210210","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-122-9-199505010-00004","article-title":"Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.","volume":"122","author":"Wong","year":"1995","journal-title":"Ann Intern Med"},{"key":"R33-23-20210210","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1478-3231.2011.02722.x","article-title":"Patient time costs and out-of-pocket costs in hepatitis C.","volume":"32","author":"Federico","year":"2012","journal-title":"Liver Int"},{"key":"R34-23-20210210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2893.2011.01563.x","article-title":"Economic burden of hepatitis C-associated diseases in the United States.","volume":"19","author":"Khoury","year":"2011","journal-title":"J Viral Hepat"},{"key":"R35-23-20210210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/hep.510310229","article-title":"The cost of hepatitis A infections in American adolescents and adults in 1997.","volume":"31","author":"Berge","year":"2000","journal-title":"Hepatology"},{"key":"R36-23-20210210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1023\/A:1015671627577","article-title":"Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees.","volume":"17","author":"Sypsa","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"R37-23-20210210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/eurpub\/ckp001","article-title":"Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.","volume":"19","author":"Sroczynski","year":"2009","journal-title":"Euro J Public Health"},{"key":"R38-23-20210210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/0003-4819-156-4-201202210-00005","article-title":"New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.","volume":"156","author":"Liu","year":"2012","journal-title":"Ann Intern Med"},{"key":"R39-23-20210210","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response. All-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.","volume":"308","author":"Van der Meer","year":"2012","journal-title":"JAMA"},{"key":"R40-23-20210210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa1100370","article-title":"Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.","volume":"366","author":"Zauber","year":"2012","journal-title":"N Engl J Med"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg201350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201350","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201306000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:45:47Z","timestamp":1786542347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201306000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2013.50","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}